IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Innate Immunotherapeutics LTD

CUSIP: BHBX6X900 | 1 institutional holders

Quarters

Q2 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

QCI Asset Management Inc45,000
0.0% of portfolio›$9
StyleTurnoverLocationFiled
QCI Asset Management Inc
45,000$90.0%N/AN/APittsford, NY2018-08-06